VALEANT PHARMACEUTICALS INTL VRX.
S
W
January 03, 2016 - 11:02am EST by
member
| 2016 | 2017 | ||||||
| Price: | 101.65 | EPS | 13 | 16 | |||
| Shares Out. (in M): | 351 | P/E | 8 | 6.5 | |||
| Market Cap (in $M): | 35,500 | P/FCF | 16 | 16 | |||
| Net Debt (in $M): | 30,000 | EBIT | 6,000 | 7,000 | |||
| TEV (in $M): | 76,000 | TEV/EBIT | 12.5 | 11 | |||
| Borrow Cost: | General Collateral | ||||||
